tiprankstipranks
Solvonis Therapeutics (GB:SVNS)
LSE:SVNS
UK Market
Want to see GB:SVNS full AI Analyst Report?

Solvonis Therapeutics (SVNS) Technical Analysis

14 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Solvonis Therapeutics’s (SVNS) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Solvonis Therapeutics is a Sell.
Solvonis Therapeutics’s (SVNS) 20-Day exponential moving average is 0.15, while Solvonis Therapeutics’s (SVNS) share price is 0.14 p, making it a Sell.
Solvonis Therapeutics’s (SVNS) 50-Day exponential moving average is 0.17, while Solvonis Therapeutics’s (SVNS) share price is 0.14 p, making it a Sell.

Solvonis Therapeutics (SVNS) Pivot Points

Aug 14, 2026, 05:33 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.12
0.13
0.13
0.14
0.14
0.15
0.15
Fibonacci
0.13
0.13
0.13
0.14
0.14
0.14
0.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Solvonis Therapeutics (SVNS) Moving Averages

Aug 14, 2026, 05:33 AM
Period
Simple
Exponential
MA5
0.14Sell
0.14Sell
MA10
0.14Buy
0.14Sell
MA20
0.15Sell
0.15Sell
MA50
0.17Sell
0.17Sell
MA100
0.21Sell
0.20Sell
MA200
0.24Sell
0.23Sell
Solvonis Therapeutics’s (SVNS) 10-Day exponential moving average is 0.14, while Solvonis Therapeutics’s (SVNS) share price is 0.14 p, making it a Sell.
Solvonis Therapeutics’s (SVNS) 100-Day exponential moving average is 0.20, while Solvonis Therapeutics’s (SVNS) share price is 0.14 p, making it a Sell.
Solvonis Therapeutics’s (SVNS) stock price is 0.14 p and Solvonis Therapeutics’s (SVNS) 50-day simple moving average is 0.17, creating a Sell signal.
Solvonis Therapeutics’s (SVNS) stock price is 0.14 p and Solvonis Therapeutics’s (SVNS) 100-day simple moving average is 0.21, creating a Sell signal.
Solvonis Therapeutics’s (SVNS) stock price is 0.14 p and Solvonis Therapeutics’s (SVNS) 200-day simple moving average is 0.24, creating a Sell signal.

Solvonis Therapeutics (SVNS) Technical Indicators

Aug 14, 2026, 05:33 AM
Name
Value
Implied Action
RSI (14)
40.52
Neutral
STOCH (9,6)
41.67
Neutral
STOCHRSI (14)
31.17
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
12.97
Buy
Williams %R
-63.64
Buy
CCI (14)
-53.78
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
46.08
Neutral
ROC
-17.65
Sell
Solvonis Therapeutics’s (SVNS) Relative Strength Index (RSI) is 40.52, creating a Neutral signal.
Solvonis Therapeutics’s (SVNS) Trend Strength Indicator (ADX) is 12.97, creating a Buy signal.
Solvonis Therapeutics’s (SVNS) Commodity Channel Index (CCI) is -53.78, creating a Neutral signal.
Solvonis Therapeutics’s (SVNS) Price Rate of Change (ROC) is -17.65, creating a Sell signal.

FAQ

Is SVNS a Buy, Hold, or Sell?
Based on SVNS’s technical indicators, SVNS is a Strong Sell.
    What is SVNS’s RSI (14)?
    SVNS’s RSI (14) is 40.52, which suggests SVNS is a Neutral.
      What is SVNS’s MACD?
      SVNS’s MACD is -0.01, which suggests SVNS is a Sell.
        What is SVNS’s 5-day moving average?
        SVNS’s 5-day moving average is 0.14, which suggests SVNS is a Sell.
          What is SVNS’s 20-day moving average?
          SVNS 20-day moving average is 0.15, which suggests SVNS is a Sell.
            What is SVNS’s 50-day moving average?
            SVNS’s 50-day moving average is 0.17, which suggests SVNS is a Sell.
              What is SVNS’s 200-day moving average?
              SVNS’s 200-day moving average is 0.24, which suggests SVNS is a Sell.
                What is SVNS’s Williams % R (14)?
                SVNS’s Williams % R (14) is -63.64, which suggests SVNS is a Buy.
                  What is SVNS’s CCI (14)?
                  SVNS’s CCI (14) is -53.78, which suggests SVNS is a Neutral.
                    What is the share price of Solvonis Therapeutics?